The US health regulator has issued a warning letter to the Drug firm Divis Laboratories at Visakhapatnam. However, the company along with few external consultants and subject matter experts are
The US health regulator has issued a warning letter to the Drug firm Divis Laboratories at Visakhapatnam. However, the company along with few external consultants and subject matter experts are






